Vectiopep, a spin-off company founded by researchers at the University of Tartu, has raised €450,000 from a syndicate of investors led by Ivo Remmelg and Dag Nurm to help the company reach the next stage of growth. The University of Tartu will also invest in Vectiopep through UniTartu Ventures, a university investment company.
